Search Results - "Salas Gay, Maria Queralt"

Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic by Mussetti, Alberto, Salas Gay, Maria Queralt, Condom, Maria, Antonio, Maite, Ochoa, Cristian, Ivan, Iulia, Jiménez Ruiz De La Torre, David, Sanz-Linares, Gabriela Isabel, Ansoleaga, Belen, Parody, Rocio, Bazarbachi, Ali, Sureda Balari, Anna

“…Introduction An increased risk of mortality has been documented in transplanted patients affected by Coronavirus Disease 2019 (COVID19) with an estimated…”
Get full text

Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP/R-CHOP-like in a Single Institution by Salas Gay, Maria Queralt, Mercadal, Santiago, Domingo Domenech, Eva, Oliveira, Ana C, Encuentra, Maite, Climent, Fina, Baca Cano, Cristina, Andrade-Campos, Marcio, De la Banda, Esmeralda, Aguilera, Carmen, Fernandez de Sevilla, Alberto, Sureda, Anna, González-Barca, Eva

“…▪ Introduction: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease and the identification of risk groups is important to plan different…”
Get full text

Long-Term Follow-up of a Prospective Phase II Trial of Extended Treatment with Rituximab in Patients with B-Cell Post-Transplant Lymphoproliferative Disease and Comparison with a Cohort of Patients Treated in Real Life. Analysis on Behalf of the Spanish Lymphoma Group (GELTAMO) by Gonzalez-Barca, Eva, Salas Gay, Maria Queralt, Capote Huelva, Francisco Javier, Gomez Codina, Jose, Panizo, Carlos, Salar, Antonio, Domingo Domenech, Eva, Bailen, Alicia, Ribera, Josep-Maria, Lopez, Andres, Briones, Javier, Muñoz, Andres, Encuentra, Maite, Fernandez de Sevilla, Alberto

“…Background and Objectives: The outcome of patients with B-cell post-transplant lymphoproliferative disorders (PTLD) has improved with the introduction of…”
Get full text

Spectrum of Infections with a Protocol of Dual T-Lymphocyte Suppression Using ATG and PTCy for Gvhd Prophylaxis in Allogeneic Transplants for High-Risk Hematological Malignancies by Prem, Shruti, Gay, Maria Queralt Salas, Law, Arjun, Lam, Wilson, Thyagu, Santhosh, Michelis, Fotios V., Kim, Dennis D., Lipton, Jeffrey H., Kumar, Rajat, Viswabandya, Auro

“…ATG and PTCy have been individually shown to reduce rates of GVHD in allogeneic transplants. We adopted a combination regimen of ATG and PT-Cy for GVHD…”
Get full text

Combination of ATG and Post-Transplant Cyclophosphamide for Gvhd Prophylaxis in Matched and Mismatched Donor Peripheral Blood Stem Cell Transplants for Myeloid Malignancies by Prem, Shruti, Gay, Maria Queralt Salas, Law, Arjun, Lam, Wilson, Thyagu, Santhosh, Michelis, Fotios V., Kim, Dennis D., Lipton, Jeffrey H., Kumar, Rajat, Viswabandya, Auro

“…ATG and post-transplant cyclophosphamide (PTCy) have been individually shown to be efficacious in reducing rates of GVHD in HLA matched and mismatched…”
Get full text